A phase II study of bevacizumab and erlotinib as initial treatment for metastatic non-squamous, non-small cell lung cancer with serum proteomic evaluation
| Autor: | Akerley, Wallace, Boucher, Kenneth, Rich, Nathan, Egbert, Lyle, Harker, Graydon, Bylund, Julie, Van Duren, Terry, Reddy, Chakravarthy |
|---|---|
| Zdroj: | In Lung Cancer March 2013 79(3):307-311 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect